were performed in two hypercholesterolemic families with two homozygous girls under basal conditions and during treatment with cholestyramine. The concentrations of serum methyl sterols, squalene, cholesterol, and triglycerides, and the responses to cholestyramine were not consistently different in the two families. However, in both families stimulation of cholesterol synthesis by cholestyramine markedly increased the methyl sterol content of serum lipoproteins both in heterozygotes (with a lowering of serum cholesterol) and in homozygotes (with virtually no lowering of serum cholesterol concentration). The bile acid and cholesterol synthesis rates were modestly low in one family and markedly high in the other both with and without cholestyramine treatment, the baseline production rates being significantly correlated with the increments in the synthesis caused by cholestyramine. The two families apparently represent low and high producing types of familial hypercholesterolemia. Cholesterol synthesis in the two homozygous girls was about twice that of their respective heterozygous parents with and without cholestyramine treatment, suggesting that the double dose of the mutant gene doubled cholesterol production. Furthermore, close child-to-parent correlations for the bile acid and cholesterol synthesis rates point to a genetic control of cholesterol metabolism.
A t the cellular level the homozygous state of famili ial xanthomatotic hypercholesterolemia is characterized by either absent, defective, or poorly functioning cell membrane receptors for low density lipoprotein (LDL). 1 " 3 Consequently, catabolism of LDL is impaired and results in a marked increase in the plasma level of LDL, i.e., in hypercholesterolemia. The production rate of LDL also appears to be enhanced, 4 " 7 but the overall cholesterol metabolism is poorly understood. In heterozygous adults cholesterol and especially bile acid synthesis is frequently subnormal 8 probably due to low hepatic cholesterol synthesis, 9 and the response to choiestyramine is low especially in subjects with a low baseline production. 10 Hepatic cholesterol synthesis of homozygous hypercholesterolemic rabbits, Watanabe rabbits, also appears to be subnormal. 11 Studies on cholesterol and bile acid synthesis in homozygous patients (mostly children) have revealed high, normal, and low production rates 6 ' 712 " 21 with no apparent relation to the LDL receptor status. 7 No family studies have been performed, however. In the present study fecal steroids were measured in two homozygous hypercholesterolemic Finnish children and their parents before and during cholestyramine treatment to learn to what extent the heterozygous state of the parents is related to cholesterol metabolism in their homozygous children. Cholesterol precursors, squalene and unesterified methyl sterols, were also determined in serum because methyl sterols, and less consistently, squaiene relay changes in cholesterol synthesis in many clinical conditions. 2223
Methods

Family Studies
The clinical data about the two families are presented in Table 1 and the serum lipids, in Table 2 .
Each family included only one child, a 4-year-old and a 5-year-old girl. No cell receptor studies for LDL were performed but the clinical, laboratory, and family findings strongly suggest that the girls were homo- zygous and their parents, heterozygous for familial hypercholesterolemia with tendon xanthomata.
The families were hospitalized under metabolic ward conditions. They consumed a standard solidfood diet low in cholesterol (1.5 mg/kg body weight daily) and unabsorbable markers (Cr ? 0 and p-sitosterol 600 mg/day each). After a stabilization period of 5 to 10 days, stool collections were made followed by cholestyramine treatment (32 g/day for the adults, 24 g/day for Child H, and 16 g/day for Child T) for 2 to 3 weeks. Blood sampling and stool collections were performed before and during the cholestyramine treatment. Previous studies showed that under these experimental conditions, a reasonably steady state of sterol metabolism was obtained both with and without cholestyramine. 24 Thus, body weight was stable, plasma lipid values leveled off, and in successive fecal samples fecal steroids showed no constant increase or decrease. In growing children the sterol balance value (i.e., the difference between dietary cholesterol and fecal elimination of cholesterol as neutral sterols and bile acids) may underestimate cholesterol synthesis because growing tissues retain some cholesterol.
The parents were informed of the nature and purpose of the investigations and the families consented to the study. The design was accepted by the ethics committee of the hospital.
Analytical Procedures
Serum cholesterol and triglycerides were measured by standard hospital laboratory methods. 2526 Stools were analyzed for neutral steroids of both cholesterol and plant sterol origin, bile acids, 27 ' a and C^Og. 29 The mean recovery of Cr O was 94% and that of B-sitosterol, 91%. Of the cholesterol precursors in serum the squalene and unesterified methyl sterol levels were determined using gas liquid chromatography for quantitation after the precursors and free cholesterol had been isolated by thin-layer chromatography. 23 Five methyl sterol fractions are quantitated in this procedure, termed Fractions I-V in increasing order of retention times. They included: lanosterol (Fraction IV); two dimethyl (4a, 4(3) sterols (A 8 = Fraction II and A 824 = Fraction V); and two monomethyl (4a) sterols (A 8 = Fraction I and A 7 = methostenol Fraction III). To eliminate the effect of Serum lipids are averages of two to four measurements; fecal steroids are averages of two to three measurements of 2-day or 3-day stool collections. Number of days of stool collections in parenthesis. marked differences in the lipoprotein levels on the precursor concentrations, the values of squalene and methyl sterols are expressed in terms of /u.g/100 mg of free cholesterol.
Results
Serum Lipids
The serum total cholesterol and triglycerides are shown in Table 2 . The baseline lipid levels and the decrease in the parents' serum cholesterol (22% to 44%) by cholestyramine use were similar in the two families. Cholestyramine increased serum triglycerides significantly ( + 34%) in Father H. In homozygous Child T, serum cholesterol was significantly lower than in Child H, and cholestyramine slightly lowered cholesterol ( -6%) in Child T but not in Child H. Child H was slightly hypertriglyceridemic, but cholestyramine increased triglycerides significantly only in Child T. No correlation was found for serum lipids between the children and their parents.
Bile Acid and Cholesterol Synthesis
Basal Synthesis Rates
The production of both bile acids and cholesterol was higher in Family T than in Family H, and the overall cholesterol synthesis of the homozygous children was about twice that of their heterozygous parents (Table 3 ). Bile acid production was low in Child H, however. The correlations of the synthesis rates between the children and their parents (r =0.912 for bile acids and r = 0.987; p < 0.05; n = 4 for cholesterol) suggest that the basal cholesterol synthesis of the children depended on that of the parents.
Synthesis Rates on Cholestyramine
Both cholesterol and bile acid synthesis, shown in Table 3 , were markedly increased by cholestyra-mine, the responses of the family members being higher in Family T than in Family H. The actual values in the children were about twice those in their parents. The correlation coefficients between the children and parents were 0.976 for bile acids and 0.989 for cholesterol. The respective values for the combined pretreatment and posttreatment data were 0.976 and 0.979 (p < 0.001, n = 8). The cholesterol synthesis rate during the treatment was closely correlated with the pretreatment value (r = 0.972, p < 0.01, n = 6). The bile acid production during cholestyramine treatment was correlated somewhat better with basal cholesterol synthesis (r = 0.928) than with bile acid synthesis (r = 0.859). The changes caused by cholestyramine in the synthesis rates were also closely correlated with the pretreatment values ( Figure 1 ).
Precursor Levels
Of the cholesterol precursors (Table 4) , serum free methyl sterols tended to be higher in Family T than in Family H both before and during cholestyramine treatment, while squalene tended to be lower. Methyl sterols and their increase during cholestyramine treatment of the homozygous Child H were quite low and lower than in her parents, while in Child T they were high and exceeded the levels of her parents. No correlation was found for squalene or methyl sterols between the children and the parents. With the exception of methostenol (Fraction III), all other methyl sterols were consistently increased by cholestyramine, the highest increase being tenfold. A statistically most significant increase occurred in lanosterol and in its next demethylation product, A 8 -2idimethylsterol (Fraction V). Squalene tended to decrease during cholestyramine treatment. The plot of the bile acid and cholesterol synthesis rates against the methyl sterol values did not show separate significant correlations before or during cholestyramine treatment. For the combined data, however, highly significant positive correlations (for Fraction V, r = 0.869 with bile acids and 0.842 with cholesterol, n = 12) were found, while the respective correlations with the squalene levels were negative (r = -0.579 and -0.648).
Discussion
The present findings indicated first, that in the homozygous children, who have a double dose of the mutant familial hypercholesterolemia gene, cholesterol synthesis is about twice that of their heterozygous parents with only one mutant gene both under the baseline conditions and especially during the cholestyramine-induced increase in cholesterol synthesis. Second, cholesterol and bile acid production may be genetically determined so that, depending on the parents, the production rates can vary from low to high in different hypercholesterolemic families. Third, differences in cholesterol metabolism between families and family members appear to be accentuated by cholestyramine because the values before and during treatment are interrelated. Fourth, cholesterol precursors in serum reflect changes in cholesterol synthesis both in heterozygous and homozygous subjects.
In addition to the present findings, the data by Bilheimer et al. 7 also show that the mean baseline cholesterol synthesis in the two homozygous children studied (22.2 and 16.6 mg/kg/day) was about I-V are different methyl sterols; I = A a -methostenol and some dihydrolanosterol; II = A 8 -dimethyl (4a, 4P) sterol; III = mainly methostenol; IV = lanosterol and V = A 824 -dimethyl (4a, 4P) sterol. Sum includes I-V. The upper values are before, the lower ones during, cholestyramine (C) administration. FCH = free cholesterol. twice that of the heterozygous mothers (10.8 and 10.8 mg/kg/day). Further, a homozygote child in the study by McNamara et al. 21 had bile acid synthesis (4.2 ± 2.0 mg/kg/day) and cholesterol synthesis (14.6 ± 3.4 mg/kg/day) about double that of his heterozygous mother (1.4 ± 0.3 and 7.8 ± 1.2 mg/kg/ day). Lack of other family studies makes it impossible to know whether this double-gene effect is seen between the parents and their homozygous children even at low cholesterol production, or whether other confounding factors such as age and diet are involved.
The effect of homozygotes being young has also been discussed. 718 ^ Baseline cholesterol production may decrease somewhat in children as they get older, 3031 but apparently this is not true in adult hypercholesterolemics. 10 High cholesterol synthesis (34.2 mg/kg/day) in an adult homozygote 20 suggests that the twofold difference between the heterozygous parents and their homozygous children in the present study need not be due to age.
The response of bile acid and cholesterol synthesis to cholestyramine is lowered by about 30% in young hypercholesterolemic adults as they get older. 10 The marked difference in the basal synthesis rates and the nearly fourfold difference between the H and T parents in the responses of their synthesis rates to cholestyramine are hardly due solely to their age difference. The similar ages of the homozygous children and the close child-to-parent correlations of the synthesis rates before and during cholestyramine treatment suggest that the family difference was genetically determined and that, in general, cholesterol and bile acid synthesis are under a strong genetic control. With an equally low cholesterol intake, the baseline synthesis rates were suppressed to low levels in Family H members, while in Family T members production continued briskly at high serum cholesterol levels.
Comparison of our present baseline and cholestyramine data with those in the literature obtained with comparable techniques is shown in Table 3 . The bile acid and cholesterol production rates of the homozygous and heterozygous members of Family H are mostly within the low limits of the published cases, but the values of Family T are clearly above the means of hypercholesterolemic or even normolipidemic subjects. It appears that both parents in Family H have hypercholesterolemia with modestly low production, while Family T parents are high producers. A heterozygote with a markedly high cholesterol production has been recently described. 32 A marked variation in the cholesterol production of the homozygotes (from 6.86 mg/kg/day 19 to 34.2 mg/kg/ day 20 ) could represent different combinations of parents with varying type of familial hypercholesterolemia. Low synthetic rates of cholesterol and bile acids in a large number of heterozygous patients suggest that low production predominates in Finnish familial hypercholesterolemia. 8 
' 1033
The positive correlation of the pretreatment production rates of bile acids and cholesterol with those during cholestyramine treatment could be due to the effectiveness of bile acid absorption both under the basal conditions and during cholestyramine treatment. In fact, the fraction of newly synthesized cholesterol eliminated as bile acids tended to be higher in the high producing Family T than in Family H (28% to 33% vs 10% to 31 %) especially during cholestyramine treatment (73% to 86% vs 63% to 73%). However, the fraction was not consistently related to cholesterol synthesis under the basal conditions. 7 The bile acid synthesis during cholestyramine treatment was actually better related to the basal cholesterol than to the bile acid synthesis (r = 0.928 vs 0.859). Since the newly synthesized hepatic cholesterol is used preferentially for bile acid production 34 " 36 it can be inferred that the cholestyramine response is high in subjects in whom the hepatocyte cholesterol requirement is predominantly covered by its own synthesis, and to a smaller extent by the uptake of plasma lipoproteins. In fact, the homozygous children who lacked receptor-mediated uptake of LDL had very high responses to cholestyramine treatment.
As compared to fecal steroids, serum methyl sterols revealed differences in cholesterol metabolism between the two families or generations under the basal conditions less consistently. The stimulation of cholesterol synthesis by cholestyramine was followed by a several-fold increase in these precursor sterols, but not of squalene, in all subjects, including the homozygous girl, H, but there was no change in serum cholesterol. Thus, in her case depletion of hepatocyte cholesterol via enhanced conversion to bile acids was apparently unable to increase the receptor-mediated uptake of LDL cholesterol, but was balanced solely by enhanced hepatic synthesis. This resulted in a three-fold increase in the methyl sterol contents of her serum lipoproteins. In general, the findings indicated that the higher the cholesterol synthesis, the higher the serum methyl sterol levels and the lower the serum squalene contents. An acute increase in hepatic cholesterol synthesis increases both serum squalene and methyl sterols. 23 During the resin-induced long-term stimulation of cholesterol synthesis, demethylation of lanosterol and rearrangement of the double bonds apparently remain rate-limiting, resulting in an accumulation of methyl sterois within hepatocytes and in enhanced release into the serum lipoproteins. As compared to normal subjects, 22 " 23 in the heterozygous and homozygous subjects none of the methyl sterols predominated, suggesting that the production and subsequent release and removal of methyl sterols were not specifically abnormal. In fact, in contrast to cholesterol, the hepatic uptake of methyl sterols may not be affected in familial hypercholesterolemia because cholesterol precursors may be metabolized on and off lipoproteins without actual catabolism of the whole lipoprotein molecule. 23 
